# MedWatch Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medwatch-technologies

- Industry: Software
- Headquarters: Las Vegas, US
- Website: www.medwatchtech.com
- Total disclosed funding: $15M
- Latest round: Series A (Jan 14, 2026)
- Investors on record: 1

## About

MedWatch Technologies, Inc. is a US-based company focused on delivering innovative health management solutions through a non-invasive platform that combines biosensing technology and AI coaching for proactive metabolic health monitoring.MedWatch Technologies, Inc. specializes in non-invasive health management solutions. Co-founded in 2022 in Nevada, United States by Mike Moore and Bruce Matichuk, the company has undertaken significant efforts to develop its innovative health platform. As of January 2026, MedWatch Technologies raised USD 15 mn in a Series A funding round led by Stead Impact Ventures, marking its first funding deal. MedWatch Technologies, Inc. is pioneering a non-invasive health management platform that integrates advanced biosensing technology with AI-driven coaching. This innovative solution is designed to provide users with a comprehensive approach to proactive health management, particularly focusing on metabolic health. The platform addresses critical health issues by enabling individuals to monitor their health metrics in real-time, facilitating timely interventions and lifestyle adjustments. The target audience includes healthcare providers, patients, and wellness enthusiasts across North America and Europe, where demand for advanced health management solutions is growing. The company's offerings are currently in development and pending FDA clearance. MedWatch Technologies, Inc. generates revenue through a subscription-based model, primarily targeting both healthcare providers and individual consumers. Clients subscribe to access the platform, which includes features such as biosensing capabilities and personalized AI coaching. Revenue transactions occur directly, with end users paying a recurring fee for ongoing access to the service, allowing for consistent revenue flow. The firm’s flagship product offers a unique value proposition that encourages user engagement and retention through its tailored health management experience, catering to a wide range of users from individual subscribers to healthcare institutions seeking comprehensive solutions. The company plans to support the growth and further development of its metabolic wellness innovation services, to launch new products focusing on enhanced health management features and is targeting expansion into additional markets within North America and Europe by the end of 2026. This strategic growth plan aims to meet the increasing demand for advanced health management solutions.

## Funding rounds

- Series A, Jan 14, 2026, $15M — Stead Impact Ventures

## Investors

- Stead Impact Ventures (https://capitalatlas.ai/funds/stead-impact-ventures) — Series A